Orchestra BioMed Holdings, Inc. (OBIO) Free cash flow 2022–2025
Orchestra BioMed Holdings, Inc. (OBIO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$49.5MFY2025 · since FY2022: -$29.9M → -$49.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$49.5M | +2.7% |
| FY2024 | -$50.8M | -10.0% |
| FY2023 | -$46.2M | -54.6% |
| FY2022 | -$29.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice